According to Arcangelo et al. (2017), the first HIV incident was discovered in the US in the 1980s; however, the number of cases has been increasing over the yeast as confirmed by CDC. HIV is treated with medicines and is referred to antiretroviral therapy. Some of the medicines available for HIV treatment include atazanavir which is taken with food, fosamprenavir which is taken without regard to food, indinavir which is taken either one hour before or two hours after meals, and saquinavir which it taken with large meals among others (Arcangelo et al. 2017). Importantly, some of the drugs may result in drug interactions, and thus, researchers have been advanced to select drug combinations with the highest efficacy. There have been improvements in the medication of HIV which assures individuals healthier and longer lives. According to Krummenacher et al. (2011), there is high persistence and retention to ART electronic drug management programs which in turn helps improve the life of people living with HIV. Additionally, Scourfield, Waters, & Nelson (2011) asserts that the new technology allows for the combination of drugs that have turned HIV/AIDS into a chronic medication condition. Thus, the main worry is the development of toxicity both in the short run and long runs. However, ART has made it possible for individuals to live nearly a normal life expectancy. In my opinion, such advancement in medication has discredited to the threats of HIV.
Due to high complacency, prevention measures have reduced at both individuals and national level. According to Lloyd (2015), ART and Prep have greatly reduced the HIV mortality but has increased number of people infected with the disease. Health care professionals can help change perception by equally increasing the prevention measures rather than focusing on management measures only. The prevention program will help in providing comprehensive information about HIV, reduce risky behaviors, and reduce substance use. Prevention is not only important at saving lives but also helps in reducing the cost of treatment. The integrated strategies should also make the people living with HIV to understand the importance of not spreading the disease to others.
Delegate your assignment to our experts and they will do the rest.
References
Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.
Krummenacher, I., Cavassini, M., Bugnon, O., & Schneider, M. P. (2011). An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS care , 23 (5), 550-561.
Lloyd, M. R. (2015). An examination of hiv/aids complacency, attitudes and sexual risk behavior among men who have sex with men: Implications for community based prevention efforts, practitioners and social work education (Doctoral dissertation, Loyola University Chicago).
Scourfield, A., Waters, L., & Nelson, M. (2011). Drug combinations for HIV: what’s new?. Expert review of anti-infective therapy , 9 (11), 1001-1011.
